Journals / İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi / 2014 / Cilt: 4 - Sayı: 2

General treatment principles in children with cholestatic liver disease

Çocukluk çağı kolestatik karaciğer hastalıklarında genel tedavi prensipleri

Pages
82–86
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, general principles of treatment in children with cholestatic liver disease were discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In children, most of the cholestatic diseases have unknown etiology and there is no spesific treatment option.
📊
Key Findings & Data:In these cases, therapy can only be directed toward supression of the pathogenetic processes and the amelioration of the consequences of cholestasis.
💡
Conclusion & Impact:In this report, general principles of treatment in children with cholestatic liver disease were discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In children, most of the cholestatic diseases have unknown etiology and there is no spesific treatment option. In these cases, therapy can only be directed toward supression of the pathogenetic processes and the amelioration of the consequences of cholestasis. By this way quality of life of the children can be promoted until the recovery of the cholestasis or progression of the cholestatic process to liver transplantation requ- irement on the other extreme treatment modalities in children with cholestatic liver disease analyzed in two groups. Specific treatment of underlining disease is placed in the first group and treatment and prevention of complications secondary to cholestasis itself is in the second group. In this report, general principles of treatment in children with cholestatic liver disease were discussed.

Özet

Çocuklarda, kolestatik hastalıkların çoğunun etiyolojisi bilinmemekte ve özgül bir tedavi seçeneği bulunmamaktadır. Bu olgularda tedavi patogenetik süreci baskılama - ya ve kolestazın sonuçlarını düzeltmeye yönelik olmaktadır. Bu şekilde, kolestaz iyileşene veya diğer uçta kolestatik süreç ilerleyerek karaciğer nakli gerektirene kadar çocukların yaşam kalitesi artırılabilmektedir. Kolestazlı hastaların tedavisi iki grupta incelenmektedir. Birinci grupta temel soruna yönelik özgül tedaviler yer almaktadır. İkinci grupta ise kolestaza ikincil olarak gelişen komplikasyonların önlenmesi ve düzeltilmesine yönelik genel tedaviler bulunmaktadır. Bu makalede kolestatik karaciğer hastalığı olan çocuklarda genel tedavi prensipleri tartışılmıştır.

🔖

Cite This Article

ERDUR, C. B., IŞIK, İ. (2014). General treatment principles in children with cholestatic liver disease. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, Cilt: 4 - Sayı: 2, 82–86. https://ajindex.com/articles/210952

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Cox KL, Berquist WE, Castillo RO. Pediatric liver transplan - tation: Indications, timing and medical complications. J Gastroenterol Hepatol 1999;14:61-6.
  2. Özen H. Kronik karaciğer hastalarının izlemi. Katkı Pediatri Dergisi 2007;29:303-21
  3. Paumgartner G, Pusl T. Medical treatment of cholestatic liver disease. Clin Liver Dis 2008;12:53-80.
  4. Los EL, Lukovac S, Verner A, et al. Nutrition for children with cholestatic liver disease. Nestle Nutr Workshop Ser Pediatr Program 2007;59:147-157
  5. Nightingale S, Ng VL. Optimizing nutritional management in children with chronic liver disease. Pediatr Clin North Am 2009;56:1161-83.
  6. Young S, Kwarta E, Azzam R, Sentogo T. Nutrition assesment and support in children with end-stage liver disease. Nutr Clin Pract 2013;28:317-329.
  7. Aydoğdu S. Kronik karaciğer hastalıklarında beslenme. Gümüşdiş G, Kokuludağ A (eds) II. Ege Dahili Tıp Günleri Özet Kitabı 2003: 145-49
  8. Okita M. Chronic hepatic disease and dietary instruction. Hepatol Res 2004;30:90-3.
  9. Özen H. Kronik karaciğer hastalığı ve kolestaziste uzun süreli izlem. Katkı Pediatri Dergisi 1999;20:157-71
  10. Carey EJ, Lindor KD. Current pharmacotherapy for cholestatic liver disease. Expert Opin Pharmacother 2012;13:2473- 84.
  11. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002;36:525-31.
  12. Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997;25:519-23.
  13. Cies JJ, Giamalis JN. Treatment of cholestatic pruritis in children. Am J Health SysT Pharm 2007;64:1157-62.
  14. Kwatra N, Shalaby-Rana E, Narayanan S, et al. Phenobarbital- enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center. Pediatr Radiol 2013;43:1365-75.
  15. Nio M, Muraji T. Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia. Pediatr Surg Int 2013;29:1091-5. ht